Medical/Pharmaceuticals
Sai Life Sciences presents mid-term report on Sai Nxt initiative; reveals upsurge in capabilities
- Completes two-thirds of its investment target of US$150M - Demonstrates a leap forward in capabilities across all focus areas – People, Processes, and Infrastructure HYDERABAD, India, Oct. 11, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development and Manufac...
2021-10-11 16:50
4465
Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma
SUZHOU, China, Oct. 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the clinical trial of ALK-1 antibody (GT90001C) and Nivolumab (O...
2021-10-11 13:00
6758
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA
GENEVA, Oct. 11, 2021 /PRNewswire/ -- 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAlliance's n...
2021-10-11 08:00
1277
Sequential Skin raise US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kit
LONDON, Oct. 11, 2021 /PRNewswire/ -- Sequential Skin Ltd
2021-10-11 06:00
3674
AXA BetterMe Weekend concludes successfully
HONG KONG, Oct. 10, 2021 /PRNewswire/ -- In response to the World Mental Health Day and celebrating the 1st anniversary of AXA BetterMe, the holistic wellness platform on the Emma by AXA app, AXA Hong Kong andMacau ("AXA") hosted the "AXA BetterMe Weekend" (the "Event") on 7-10 October at Hysan P...
2021-10-10 17:54
4968
Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease
DURHAM, N.C. and BEIJING, Oct. 9, 2021 /PRNewswire/ -- Brii Biosciences
2021-10-09 03:07
6486
Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction
BOAO, China, Oct. 8, 2021 /PRNewswire/ -- On September 30, 2021 (Hainan-Bo'ao), Hongkong Winhealth Pharma Group (Winhealth Pharma) and the China Alliance for Rare Disease (CARD) officially signed a five-year strategic collaboration agreement. The cooperation involved rare disease registration and...
2021-10-08 23:01
4314
VIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in Italy
MELBOURNE, Australia, Oct. 8, 2021 /PRNewswire/ -- Australian biotech company Starpharma today announced it has signed a sales and distribution agreement for its VIRALEZE™ antiviral nasal spray with ADMENTA Italia Group (ADMENTA), a leading pharmaceutical retail and wholesale distribution company...
2021-10-08 13:51
6279
Findings in New Book, Neurology in Migrants and Refugees, Presented at the World Congress of Neurology 2021, Raising Awareness on Neurological Issues Facing Migrants and Refugees
LONDON, Oct. 8, 2021 /PRNewswire/ -- Medical professionals around the world now have a new resource to help them understand the challenges of treating and caring for migrants and refugees with neurological problems, thanks to a new book authored by a Specialty Group of neurologists and neuroscien...
2021-10-08 12:12
2540
ProfoundBio Announces Presentation on Novel, Proprietary Linker-Drug Technology to Enable Antibody-Drug Conjugates (ADCs) with an Expanded Therapeutic Window at the AACR-NCI-EORTC International Conference
WOODINVILLE, Wash. and SUZHOU, China, Oct. 7, 2021 /PRNewswire/ -- ProfoundBio announces that preclinical data from its novel, proprietary ADC technology platform are being presented at the 2021 Molecular Targets and Cancer Therapeutics conference hosted by the American Association for Cancer Res...
2021-10-08 11:39
3146
CStone presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
SUZHOU, China, Oct. 8, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the data on the preclini...
2021-10-08 08:00
4801
Medtecs debuts in world's leading nonwovens exhibition - INDEX(TM)20
TAIPEI, Oct. 7, 2021 /PRNewswire/ -- As the world explores ways to "coexist with the virus," personal protective equipment (PPE) such as face masks and coveralls have become a new normal. Use of anti-viral sprays has become commonplace too. In light of this, Medtecs, a trusted and well-establishe...
2021-10-07 22:12
3782
Breakthrough for medtech pioneer: Syntellix receives product approval for India, opening up fast-growing market with 1.38 billion people
Syntellix CEO Claassen: "Greatest and most important success in the company's history" - Indian CDSCO grants approvals for five MAGNEZIX® product families - The Era of Magnesium for orthopaedics and traumatology now also begins in India - Subcontinent will be the world's most populous growth m...
2021-10-07 22:08
2961
Medtecs participates for the first time in world's leading nonwovens exhibition - INDEX(TM)20 in Europe
TAIPEI, Oct. 7, 2021 /PRNewswire/ -- The threat of COVID-19 continues. As vaccine development fails to keep up with the rate the virus mutates, countries around the world have started exploring ways to "coexist with the virus," meaning that personal protective equipment (PPE) such as face masks a...
2021-10-07 21:28
5103
Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers
HOUSTON and SINGAPORE, Oct. 7, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced the presentation of pre-clinical data on novel biomarkers for HER3-driven cancers at the...
2021-10-07 21:03
2284
Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence at High Point, NC Facility
EAST RUTHERFORD, N.J., Oct. 7, 2021 /PRNewswire/ -- Cambrex today announced that it is expanding its manufacturing center of excellence inHigh Point, NC. The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services. The ...
2021-10-07 20:30
3674
CDD Gives Back with Open Access Data Visualization Tool
SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD) announced today that it is providing a full featured, standalone software tool to the scientific community for free.CDD Visualization is an intuitive browser-based application that allows scientists to visualize ...
2021-10-07 17:57
2540
Solving the Mystery of Sleep by "Lighting Up the Brain" presented at WCN 2021 by Neuroscientist Gero Miesenböck
LONDON, Oct. 7, 2021 /PRNewswire/ -- Solving the mystery of sleep by studying brain mechanisms that regulate sleep and waking was research presented by Gero Miesenböck, Waynflete Professor of Physiology at the Centre for Neural Circuits and Behavior,Oxford, England at the virtual 25th Biennial Wo...
2021-10-07 17:46
1802
Deep Longevity Launches Longevity Medicine Course for Physicians with Industry Experts
HONG KONG, Oct. 7, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s Deep Longevity, Inc, a company acquired on14 December 2020 which develops artificial intelligence to track human aging and ...
2021-10-07 15:30
11819
Ascensia Diabetes Care Launches the "This is Diabetes" Competition to Highlight the Need for Access to Diabetes Care in Support of IDF's World Diabetes Day
BASEL, Switzerland, Oct. 7, 2021 /PRNewswire/ -- Today Ascensia Diabetes Care, makers of the CONTOUR® Blood Glucose Monitoring system portfolio and distributors of the Eversense® Continuous Glucose Monitoring system, has launched its "This is Diabetes" art and photography competition as the comp...
2021-10-07 15:00
2610
Week's Top Stories
Most Reposted
Visa Expands Support for its Clients and the Industry as Organisations Navigate New AI Era of Cybersecurity
[Picked up by 315 media titles]
2026-08-28 09:01Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
[Picked up by 313 media titles]
2026-08-27 10:25
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
[Picked up by 304 media titles]
2026-08-24 10:00
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
[Picked up by 297 media titles]
2026-08-25 10:00OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
[Picked up by 291 media titles]
2026-08-24 15:42
Most Read
OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
2026-08-24 15:42
19959
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
2026-08-24 10:00
19833
Rewarding Meetings Begin At Hyatt Regency Kuala Lumpur At KL Midtown
2026-08-25 07:00
17794
Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
2026-08-27 10:25
13441